Anthropic AI for Science — Rare Disease Research Grants
Anthropic
Claude API credits for rare-disease research, announced July 20, 2026, with access to Claude Opus and approved biology models. Two tracks: Basic Science Partnerships, linking clinical researchers, patient organizations, and data scientists to accelerate discovery of disease mechanisms in partnership with the Monarch Initiative (Mondo Disease Ontology, DisMech mechanistic classification); and Biotech Partnerships for early-stage companies, covering regulatory drafting, therapeutic strategy, and shared-mechanism basket trials.
BTHS-applicable uses include literature synthesis and mechanism-mining for TAFAZZIN and cardiolipin labs, and drug-development support for a future BTHS biotech. The inaugural window closed Aug 2, 2026; Anthropic has signalled future rare-disease hackathons and community-building.
Academic scientists doing basic rare-disease research, patient organizations partnering with researchers, and early-stage biotechs developing rare-disease treatments.
The 2026 window (closed Aug 2, 2026, 11:59 PM PST) used a short application form linked from the announcement. Future cycles and hackathons would be announced on the same page.
/grants/anthropic-ai-for-science-rare-disease-research-grants/
Last updated August 28, 2026 · Suggest an update to this entry